Daily Cosmetic Research Analysis
Analyzed 21 papers and selected 3 impactful papers.
Summary
Three impactful studies span image-guided aesthetic surgery, regenerative hair science, and behavioral economics in skin cancer prevention. Ultrasound integration into facial fat grafting shows safety and objective volumetric tracking benefits; exosome-mediated scalp rejuvenation delineates a miR-21-5p/DKK2/Wnt/COL17A1 axis outperforming minoxidil in mice; and a game-theoretic model explains underuse of sunscreens, highlighting policy levers.
Research Themes
- Ultrasound-guided aesthetic procedures
- Exosome-based regenerative dermatology
- Behavioral economics of sunscreen use and melanoma prevention
Selected Articles
1. Ultrasound-Assisted Facial Autologous Fat Grafting: A Systematic Review of Perioperative Safety and Volumetric Outcomes.
Across 12 studies (885 patients), HFUS aided pre/intra/postoperative decision-making in facial AFG, enabling safer plane confirmation, filler characterization, and objective retention tracking. One comparative cohort showed larger injection volumes and higher satisfaction without increased complications, with ultrasound-tracked retention stabilizing around 50–70% by 1 year.
Impact: Synthesizes emerging evidence that ultrasound can improve safety and standardize monitoring in facial fat grafting, an area prone to rare but severe vascular complications and variable retention.
Clinical Implications: Clinicians can consider HFUS for vascular mapping, identifying prior fillers, confirming cannula planes in real time, and tracking retention to guide staged grafting. Adoption should be paired with standardized ultrasound protocols and training.
Key Findings
- Twelve studies (885 patients) reported HFUS utility for vascular mapping, filler characterization, safe-plane confirmation, and postoperative monitoring.
- In a comparative temple augmentation cohort, ultrasound guidance increased injection volume (22.32±5.19 vs 10.55±2.25 mL) and satisfaction (92% vs 74%) without more complications.
- Ultrasound-measured fat retention declined over 3–6 months and stabilized at approximately 50–70% by 1 year; supplementary grafting improved retention in one cohort (49.4% vs 71.7%).
Methodological Strengths
- PRISMA-compliant review with PROSPERO registration
- Objective ultrasound-based volumetric assessments reported across studies
Limitations
- Predominantly observational, single-center designs with heterogeneity precluded meta-analysis
- Lack of standardized ultrasound protocols and core outcome sets
Future Directions: Prospective comparative trials with standardized HFUS protocols, operator training, and core outcome sets, including cost-effectiveness and patient-reported outcomes.
High-frequency ultrasound (HFUS) is increasingly used to map facial vasculature and tissue planes, identify prior fillers, and objectively assess volume after autologous facial fat grafting (AFG), but its perioperative benefit has not been systematically synthesized. We performed a PRISMA-compliant systematic review (PROSPERO registration: CRD420251242117), searching PubMed, Embase, Web of Science Core Collection, and the Cochrane Library from inception to November 1, 2025, without language restrictions. We included human clinical studies using B-mode and/or Doppler ultrasound preoperatively, intraoperatively, or postoperatively and reporting safety and/or volumetric outcomes. Methodological quality was assessed using National Institutes of Health tools; due to heterogeneity, findings were narratively synthesized. Twelve studies (885 patients; 2017-2024) were included, predominantly single-center observational designs. Across studies, HFUS supported vascular mapping and filler characterization, real-time confirmation of cannula location within intended planes ("safe layers"), and postoperative monitoring of retention and complications. In a comparative temple augmentation cohort, ultrasound guidance enabled higher injection volumes (22.32±5.19 vs 10.55±2.25 mL) and higher satisfaction (92% vs 74%) without increased complications. Ultrasound-measured retention typically declined during the first 3-6 months and then stabilized, with ∼50-70% retention at 1 year and higher retention after supplementary grafting (49.4% vs 71.7% in one cohort). No study reported blindness, stroke, or skin necrosis; adverse events were generally mild and transient. Overall, HFUS-assisted facial AFG appears promising for risk stratification and objective monitoring, but higher-quality comparative studies with standardized ultrasound protocols and core outcome sets are needed.
2. Mesenchymal stem cell-derived exosomes promote scalp rejuvenation through type XVII collagen regulation via the miR-21-5p/DKK2/Wnt pathway.
hUC-MSC exosomes reduced senescence markers, restored COL17A1, and enhanced hair regeneration in mice, surpassing minoxidil. Mechanistically, abundant exosomal miR-21-5p directly targets DKK2, relieving Wnt inhibition, activating β-catenin signaling, and upregulating COL17A1; inhibition of miR-21-5p blunted these effects.
Impact: Defines a mechanistic, cell-free strategy for hair follicle rejuvenation via a miRNA/DKK2/Wnt/COL17A1 axis and demonstrates superior regrowth to minoxidil in vivo.
Clinical Implications: Suggests a tractable exosome-based therapeutic avenue for androgenetic alopecia or age-related hair thinning, pending human safety, dosing, delivery optimization, and GMP manufacturing.
Key Findings
- Exosome treatment reduced SA-β-gal-positive cells from 67.5% to 21.4% and increased COL17A1 mRNA 2.67-fold with near-restored protein levels.
- Hair follicle elongation increased by 47.4%, and mice achieved 92.4% hair coverage versus 45.6% controls, outperforming minoxidil (78.3%).
- miR-21-5p was the most abundant exosomal miRNA, directly targeting DKK2 to activate Wnt/β-catenin and upregulate COL17A1; miR-21-5p inhibition partially abrogated effects.
Methodological Strengths
- Multilevel evaluation with cellular assays and in vivo hair regrowth readouts
- Mechanistic dissection linking exosomal miRNA (miR-21-5p) to a defined target (DKK2) and pathway activation
Limitations
- Preclinical models; absence of human clinical data
- Exosome heterogeneity and translational challenges in large-scale, standardized manufacturing and delivery
Future Directions: Phase 1 trials assessing safety/tolerability, dose-ranging and delivery routes, biodistribution, and comparative efficacy versus standard agents; development of GMP-grade, characterized exosome products.
BACKGROUND: Hair follicle aging is driven by COL17A1 proteolysis in hair follicle stem cells (HFSCs). Mesenchymal stem cell (MSC)-derived exosomes show promise in tissue regeneration, but their effects on COL17A1 and hair follicle aging remain unexplored. METHODS: Exosomes isolated from human umbilical cord MSCs (hUC-MSCs) were evaluated in H RESULTS: Exosome treatment reduced SA-β-gal-positive cells from 67.5% to 21.4%, upregulated COL17A1 mRNA by 2.67-fold (with protein restoration to 0.89-fold of control levels), enhanced hair follicle elongation by 47.4%, and achieved 92.4% hair coverage in mice versus 45.6% for controls, outperforming minoxidil (78.3%). miR-21-5p was identified as the most abundant exosomal miRNA and confirmed to directly target DKK2, a Wnt antagonist. DKK2 suppression was associated with Wnt/β-catenin pathway activation and upregulation of COL17A1 expression. miR-21-5p inhibitor partially blocked exosome effects, validating this axis. CONCLUSION: hUC-MSC-derived exosomes attenuate hair follicle senescence and promote hair regeneration through the miR-21-5p/DKK2/Wnt/β-catenin/COL17A1 axis, providing a promising cell-free strategy for scalp rejuvenation.
3. Game theory and environmental health behavior: a population model of sunscreen use, social norms, and melanoma incidence.
An evolutionary game-theoretic model calibrated to Australian data shows sunscreen adoption can converge to non-use when private benefits are perceived below costs, despite societal optimality. The findings frame sunscreen as a public goods problem and motivate subsidies, mandates, and norm-shifting interventions to increase uptake in high-UV, high-risk settings.
Impact: Provides a rigorous behavioral framework explaining persistent underuse of sunscreen and identifies concrete policy levers to align incentives and reduce melanoma burden.
Clinical Implications: Clinicians can incorporate cost–benefit framing and norm-based counseling; public health can test subsidies, school/workplace mandates, and social campaigns to shift equilibria toward adoption.
Key Findings
- Evolutionary game-theoretic model with payoffs including private benefits, costs, and healthcare externalities was developed and calibrated to Australian data.
- Populations converge to non-adoption when private benefits are lower than costs, even if sunscreen use is socially optimal.
- Under-adoption is pronounced in high-risk populations, implying need for policies such as subsidies, mandates, and social norm interventions.
Methodological Strengths
- Evolutionary game-theory framework linking individual incentives to population-level equilibria
- Calibration with real-world Australian data to enhance external relevance
Limitations
- Model-based analysis relies on assumptions and simplified payoffs; no empirical intervention testing
- Calibration context limited to Australia, which may limit generalizability
Future Directions: Field experiments testing subsidies, mandates, and norm-based messaging; integration with cost-effectiveness models and heterogeneous risk preferences across populations.
INTRODUCTION: Melanoma is a largely preventable yet economically significant cancer, particularly in high-UV regions. Despite strong evidence that sunscreen reduces melanoma risk, its use remains suboptimal due to misaligned private and social incentives. METHODS: We develop an evolutionary game-theoretic model in which individuals choose between sunscreen use and non-use. Payoffs incorporate private benefits, costs, and externalities from shared healthcare financing. The model is calibrated using Australian data. RESULTS: Behavior is driven by private incentives. When private benefits are lower than costs, populations converge to non-adoption, even when sunscreen use is socially optimal. Calibration shows this divergence arises in high-risk populations. DISCUSSION: Sunscreen use represents a public goods problem with under-adoption driven by externalities. Policies such as subsidies, mandates, and social norm interventions are required to align incentives and improve public health outcomes.